Invesco Nasdaq Biotechnology ETF Rating $33.87 +0.44 (+1.32%) As of 11:17 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.66Holdings in IBBQ have an aggregate rating of Moderate Buy based on 550 analyst ratings issued in the past year covering 25 companies (64.6% of the portfolio).IBBQ Aggregate Price Target$33.33-1.60% DownsideHigh Prediction$33.33Average Prediction$33.33Low Prediction$33.33Holdings in IBBQ have an aggregate price target of $33.33 and a range of $33.33 to $33.33 covering 25 companies (64.6% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings8.42%GILDGilead Sciences$151.39+2.3%Moderate Buy$159.33 5.2%293.485 of 5 starsAnalyst ForecastAnalyst Revision7.94%AMGNAmgen$425.76+3.1%Hold$387.93 -8.9%303.6194 of 5 starsAnalyst ForecastAnalyst Revision7.74%VRTXVertex Pharmaceuticals$494.09+1.8%Moderate Buy$579.81 17.4%284.0074 of 5 stars5.39%MRNAModerna$217.36+0.5%Hold$100.60 -53.7%261.7674 of 5 stars5.12%REGNRegeneron Pharmaceuticals$765.89+1.7%Moderate Buy$834.24 8.9%314.5929 of 5 starsPositive News2.76%RVMDRevolution Medicines$194.39+3.2%Moderate Buy$234.81 20.8%243.072 of 5 starsAnalyst Forecast2.74%ILMNIllumina$269.85-0.5%Hold$225.94 -16.3%182.9484 of 5 starsAnalyst Upgrade2.21%BIIBBiogen$230.38+0.6%Moderate Buy$236.04 2.5%322.6114 of 5 starsAnalyst Upgrade2.06%ALNYAlnylam Pharmaceuticals$224.89+0.5%Moderate Buy$366.50 63.0%254.1883 of 5 stars1.72%RPRXRoyalty Pharma$58.28+3.0%Buy$61.57 5.6%83.8231 of 5 stars1.69%ROIVRoivant Sciences$33.81+1.4%Moderate Buy$45.64 35.0%142.7517 of 5 starsAnalyst Downgrade1.57%INCYIncyte$110.99+2.2%Moderate Buy$128.20 15.5%253.9701 of 5 starsAnalyst ForecastGap Up1.57%UTHRUnited Therapeutics$540.89-0.5%Moderate Buy$639.08 18.2%144.092 of 5 starsTrending NewsAnalyst ForecastInsider Trade1.52%GHGuardant Health$164.54+1.5%Moderate Buy$190.00 15.5%252.2477 of 5 starsAnalyst Forecast1.52%ARGXargenex$827.81+3.1%Moderate Buy$1,151.95 39.2%304.6442 of 5 starsAnalyst Forecast1.50%INSMInsmed$98.01+1.3%Moderate Buy$200.30 104.4%252.5709 of 5 starsTrending NewsAnalyst ForecastOptions VolumeAnalyst Revision1.37%VTRSViatris$17.59+1.9%Moderate Buy$20.50 16.6%93.3811 of 5 stars1.15%MEDPMedpace$616.52+1.1%Hold$607.73 -1.4%132.6766 of 5 starsUpcoming Earnings1.00%EXELExelixis$60.80+2.2%Hold$50.79 -16.5%202.3427 of 5 starsAnalyst Revision0.99%JAZZJazz Pharmaceuticals$215.18+2.3%Buy$291.25 35.4%204.2429 of 5 stars0.98%NBIXNeurocrine Biosciences$136.09+0.7%Moderate Buy$201.14 47.8%244.8341 of 5 starsAnalyst Forecast0.94%ASNDAscendis Pharma A/S$225.30+0.9%Buy$313.21 39.0%204.8061 of 5 starsAnalyst Forecast0.94%SMMTSummit Therapeutics$15.40-0.7%Moderate Buy$28.61 85.7%192.4713 of 5 starsUpcoming EarningsOptions Volume0.89%BBIOBridgeBio Pharma$63.93+1.0%Moderate Buy$105.42 64.9%243.9037 of 5 stars0.86%ONCBeOne Medicines$352.50+1.0%Buy$404.93 14.9%173.9933 of 5 stars This page (NASDAQ:IBBQ) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
